Clinical Trial Update: Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

CVM-1118 is being studied in a Phase 2 trial for advanced neuroendocrine tumors. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor
• Lung Neuroendocrine Tumor
• Neuroendocrine Carcinoma
• Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• CVM-1118

Snippet

Sponsor: TaiRx, Inc. | Conditions: Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING